source
- Eli Lilly partners with China’s InnoCare on drug development deal worth up to $3.35 billionEli Lilly has signed a partnership agreement with Beijing-based InnoCare to co-develop new medicines. InnoCare will apply its internal drug discovery platform while Lilly will contribute its devel…
- FDA nominee Heidi Overton avoids taking positions in Senate hearing on vaccines, China and abortionHeidi Overton, President Trump’s pick to lead the Food and Drug Administration, appeared before the Senate health committee for a two hour hearing. Senators focused their questions on China, vaccin…